Results 171 to 180 of about 21,210 (213)

High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains. [PDF]

Elife
Kikawa C, Loes AN, Huddleston J, Figgins MD, Steinberg P, Griffiths T, Drapeau EM, Peck H, Barr I, Englund JA, Hensley SE, Bedford T, Bloom JD.   +12 more
europepmc   +1 more source

Genetic and Serological Analysis of H7N3 Avian Influenza Viruses in Mexico for Pandemic Risk Assessment. [PDF]

Viruses
Ayora-Talavera G, López-Martínez I, Barrera-Badillo G, Aparicio-Antonio R, Aréchiga-Ceballos N, Aguirre-Barbosa A, Wong-Chew RM, Canul-Canul D, Solís-Hernández M.   +8 more
europepmc   +1 more source

The Elicitation of an Antigen-Specific Antibody Immune Response Using a Nanoparticulate Adjuvant Derived from <i>Saponaria officinalis</i>. [PDF]

Molecules
Bogoyavlenskiy A, Alexyuk M, Alexyuk P, Omirtayeva E, Zaitseva I, Moldakhanov Y, Anarkulova E, Berezin V.   +7 more
europepmc   +1 more source

Differences in Glycoproteins and the Potential for Early Protection Using LAIV Based on Drift Variants of the A/H1N1pdm09 Influenza Virus. [PDF]

Vaccines (Basel)
Desheva Y, Mayorova I, Rekstin A, Sokolovsky D, Kudar P, Kopylova N, Guzenkov D, Petrachkova D, Mamontov A, Trullioff A, Kiseleva I.   +10 more
europepmc   +1 more source

Influenza A(H3N2) subclade K (J.2.4.1) viruses associated with a surge at a university health clinic, Arizona, the United States, November to early December 2025. [PDF]

Euro Surveill
Scotch M, Faleye TO, Urquidez-Negrete A, Bobbett B, Boyle V, Conard K, Sublasky-Rodriguez L, Murugan V.   +7 more
europepmc   +1 more source

HA Protein acetylation modulates replication, pathogenicity, and immunogenicity of influenza virus and facilitates live-attenuated vaccine design. [PDF]

Emerg Microbes Infect
Wu M, Wang M, Zeng X, Zhang K, Wang M, Xu G, Wang Z, Cheng Y, Wang H, Yan Y, Sun J, Ma J.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

TMPRSS2 Activates Hemagglutinin-Esterase Glycoprotein of Influenza C Virus

Journal of Virology, 2021
Influenza C virus (ICV) is a pathogen that causes acute respiratory illness, mostly in children, but there are no anti-ICV drugs. ICV has only one kind of spike protein, the hemagglutinin-esterase (HE) glycoprotein on the virion surface, which possesses receptor-binding, receptor-destroying, and membrane fusion activities.
Ko Sato, Hideki Hayashi, Yoshitaka Shimotai, Mutsuo Yamaya, Seiji Hongo, Kazuyoshi Kawakami, Yoko Matsuzaki, Hidekazu Nishimura   +7 more
openaire   +2 more sources

Fusion mutants of the influenza virus hemagglutinin glycoprotein

Cell, 1985
The influenza virus hemagglutinin (HA) mediates viral entry into cells by a low pH induced membrane-fusion event in endosomal vesicles. Mutant viruses with altered pH dependence for both hemolysis and the HA conformational change required for fusion were selected for their ability to grow in cells treated with amantadine hydrochloride, which raises the
R S, Daniels, J C, Downie, A J, Hay, M, Knossow, J J, Skehel, M L, Wang, D C, Wiley   +6 more
openaire   +2 more sources

Membrane fusion activity of reconstituted vesicles of influenza virus hemagglutinin glycoproteins

Biochimica et Biophysica Acta (BBA) - Biomembranes, 1983
Reconstituted vesicles of hemagglutinin glycoproteins into egg yolk phosphatidylcholine/spin-labeled phosphatidylcholine/cholesterol (molar ratio 1.6:0.4:1) were prepared by dialysis. Preparations at appropriate protein-to-lipid ratios (1:44 and 1:105 mol/mol) contained vesicles with a diameter of 100-300 nm and a high density of spikes on the surface.
K, Kawasaki, S B, Sato, S, Ohnishi
openaire   +2 more sources